Beckman Coulter will develop a companion diagnostic to help select patients for Transgene's cancer candidate TG4010

Beckman Coulter Inc.

U.S. / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Transgene S.A.

France / Small-Cap Biopharma (<$1 billion)

$581.6m on 12/31/2010 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced